China

China’s Akeso, hailed as biotech’s ‘DeepSeek moment’, falls despite nod for cancer drug

   Download Android App    Share in      FullScreen   CheckVideos

Chinese regulator grants second approval for lung cancer drug ivonescimab, which has outperformed Mercks Keytruda in phase three trial.




Unlimited Portal Access + Monthly Magazine - 12 issues

Contribute US to Start Broadcasting - It's Voluntary!

ADVERTISE

Merchandise (Peace Series)

 

Details
Category: China